Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.22 trillion and total revenue of $109.89 billion.
Market Cap
1.22T
Revenue
109.89B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.55%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.97B | 1.96% | 271,492 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.95B | 0.83% | 156,926 | 14.92B |
| 3 | ARGX | argenx SE | 52.88B | 3.74% | 204,644 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.90B | -0.91% | 283,952 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 38.53B | 6.75% | 2,084,807 | - |
| 6 | RPRX | Royalty Pharma plc | 31.67B | 1.31% | 938,442 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 30.96B | 0.50% | 54,415 | 5.70B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.85B | 1.60% | 2,558,552 | 8.26M |
| 9 | MRNA | Moderna, Inc. | 24.13B | 0.65% | 1,916,009 | 2.23B |
| 10 | INSM | Insmed Incorporated | 23.09B | 2.95% | 1,128,209 | 819.56M |
| 11 | BNTX | BioNTech SE | 22.90B | 0.38% | 193,412 | 3.23B |
| 12 | INCY | Incyte Corporation | 22.11B | 2.02% | 328,747 | 5.36B |
| 13 | ASND | Ascendis Pharma A/S | 16.18B | 9.42% | 719,833 | 998.25M |
| 14 | GMAB | Genmab A/S | 15.91B | 1.22% | 569,291 | 3.90B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.48B | 0.42% | 94,600 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.68B | 0.71% | 707,178 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.43B | 1.04% | 424,983 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.89B | 1.91% | 696,663 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.50B | 2.08% | 289,473 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 1.55% | 117,227 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.58B | 2.97% | 625,789 | 622.01M |
| 22 | CYTK | Cytokinetics, Incorporated | 11.19B | 1.49% | 379,676 | 105.82M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.15B | 0.63% | 301,649 | 3.24B |
| 24 | SMMT | Summit Therapeutics Inc. | 11.09B | 0.28% | 1,200,822 | - |
| 25 | TECH | Bio-Techne Corporation | 11.03B | 19.61% | 29,982,299 | 1.21B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.63B | 3.75% | 92,998 | 417.30M |
| 27 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.09% | 2,366,622 | - |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.83B | 19.67% | 1,893,190 | 51.48M |
| 29 | NUVL | Nuvalent, Inc. | 9.76B | -0.02% | 323,529 | - |
| 30 | CORT | Corcept Therapeutics Incorporated | 9.26B | 5.75% | 241,429 | 769.10M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.07B | 5.27% | 156,371 | 7.46M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.65B | 2.46% | 374,136 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 8.12B | -0.64% | 3,308,956 | 140.98M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 8.09B | 2.97% | 244,297 | 74.06M |
| 35 | PCVX | Vaxcyte, Inc. | 8.03B | 3.17% | 251,004 | - |
| 36 | IMVT | Immunovant, Inc. | 8.02B | 2.25% | 321,247 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.76B | 2.15% | 459,912 | 700.35M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.73B | 3.28% | 500,731 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.52B | 2.02% | 147,445 | 217.17M |
| 40 | ABVX | ABIVAX Société Anonyme | 7.31B | -0.78% | 744,087 | 5.67M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.21B | 2.88% | 170,860 | 569.61M |
| 42 | PTCT | PTC Therapeutics, Inc. | 7.15B | 2.17% | 903,087 | 827.11M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.74B | 5.06% | 991,368 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.35B | 1.29% | 507,957 | - |
| 45 | CGON | CG Oncology, Inc. | 6.24B | 2.90% | 433,488 | 5.07M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 5.97B | 4.55% | 251,891 | 274.48M |
| 47 | BLTE | Belite Bio, Inc | 5.95B | 0.39% | 40,582 | - |
| 48 | TVTX | Travere Therapeutics, Inc. | 5.57B | 3.78% | 1,250,909 | 536.20M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | 2.40% | 241,192 | 7.50M |
| 50 | CAI | Caris Life Sciences, Inc. | 5.50B | 7.22% | 1,399,761 | 907.29M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.45B | 5.56% | 896,775 | 4.10M |
| 52 | LEGN | Legend Biotech Corporation | 5.34B | -2.08% | 367,858 | 1.14B |
| 53 | ORKA | Oruka Therapeutics, Inc. | 5.25B | 6.03% | 355,623 | - |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 5.12B | 3.18% | 311,504 | 1.34M |
| 55 | DFTX | Definium Therapeutics, Inc. | 5.00B | 8.71% | 3,197,093 | - |
| 56 | MANE | Veradermics, Incorporated | 4.94B | 0.74% | 190,330 | - |
| 57 | CELC | Celcuity Inc. | 4.93B | 4.88% | 481,944 | - |
| 58 | ERAS | Erasca, Inc. | 4.68B | -0.07% | 1,828,309 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.63B | 1.80% | 189,017 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.48B | 1.93% | 1,625,012 | - |
| 61 | TNGX | Tango Therapeutics, Inc. | 4.38B | 4.05% | 1,337,935 | 56.99M |
| 62 | DNLI | Denali Therapeutics Inc. | 4.11B | 4.39% | 269,981 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.08B | 3.77% | 724,894 | 10.68M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 4.07B | 1.63% | 407,560 | 1.10B |
| 65 | RCUS | Arcus Biosciences, Inc. | 3.91B | 7.88% | 830,193 | 236.00M |
| 66 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.85B | 1.02% | 319,897 | 18.07M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.06% | 266,110 | 596.96M |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.81B | -0.18% | 484,331 | 22.57M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.67B | - | 26,507 | 803.79M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.51B | 2.64% | 164,339 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.51B | 2.56% | 443,940 | 415.62M |
| 72 | BEAM | Beam Therapeutics Inc. | 3.50B | 3.83% | 625,961 | 164.01M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.48B | 3.44% | 622,152 | - |
| 74 | PBLS | Parabilis Medicines, Inc. | 3.46B | -0.53% | 204,549 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | 2.56% | 394,020 | 225.27M |
| 76 | ALMS | Alumis Inc. | 3.26B | 3.02% | 333,685 | 8.40M |
| 77 | QURE | uniQure N.V. | 3.13B | 1.56% | 801,717 | 18.09M |
| 78 | ELVN | Enliven Therapeutics, Inc. | 3.05B | 4.88% | 506,545 | - |
| 79 | RARE | Ultragenyx Pharmaceutical Inc. | 2.98B | 4.33% | 641,375 | 670.00M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.95B | 4.05% | 668,137 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.92B | 1.05% | 65,671 | 535.08M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.77B | 4.47% | 323,290 | 865.00K |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.75B | -0.66% | 43,522 | - |
| 84 | IRON | Disc Medicine, Inc. | 2.68B | -0.13% | 124,779 | - |
| 85 | TRVI | Trevi Therapeutics, Inc. | 2.53B | 1.66% | 382,260 | - |
| 86 | MBX | MBX Biosciences, Inc. | 2.45B | 6.46% | 325,836 | - |
| 87 | PHVS | Pharvaris N.V. | 2.43B | 4.51% | 137,692 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.39B | -0.38% | 568,664 | 298.30M |
| 89 | IMNM | Immunome, Inc. | 2.33B | 4.30% | 459,902 | 4.02M |
| 90 | KOD | Kodiak Sciences Inc. | 2.33B | 3.50% | 345,858 | - |
| 91 | BHVN | Biohaven Ltd. | 2.32B | 3.21% | 1,118,896 | - |
| 92 | NRIX | Nurix Therapeutics, Inc. | 2.32B | 16.11% | 2,278,151 | 71.78M |
| 93 | NTLA | Intellia Therapeutics, Inc. | 2.25B | 3.74% | 1,234,762 | 66.09M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.23B | 3.20% | 559,053 | 52.04M |
| 95 | GENB | Generate Biomedicines, Inc. | 2.22B | 6.90% | 261,811 | 30.30M |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | 2.45% | 168,582 | 66.05M |
| 97 | VCEL | Vericel Corporation | 2.21B | 3.74% | 159,595 | 292.09M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 2.19B | 3.20% | 202,099 | - |
| 99 | NKTR | Nektar Therapeutics | 2.15B | -1.67% | 165,980 | 55.63M |
| 100 | ZLAB | Zai Lab Limited | 2.08B | 0.98% | 183,506 | 453.28M |
| 101 | NUVB | Nuvation Bio Inc. | 2.07B | -8.13% | 5,233,699 | 143.05M |
| 102 | ADMA | ADMA Biologics, Inc. | 2.06B | 2.01% | 720,715 | 509.86M |
| 103 | ABCL | AbCellera Biologics Inc. | 2.00B | 8.87% | 4,656,033 | 79.21M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.00B | 0.26% | 72,043 | 899.11M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 1.99B | 4.14% | 155,269 | 20.00M |
| 106 | PGEN | Precigen, Inc. | 1.99B | 3.15% | 1,580,518 | 31.60M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.98B | 6.94% | 93,888 | - |
| 108 | KARD | Kardigan, Inc. | 1.97B | -0.05% | 49,632 | - |
| 109 | PVLA | Palvella Therapeutics, Inc. | 1.97B | 5.63% | 72,437 | - |
| 110 | STOK | Stoke Therapeutics, Inc. | 1.96B | 3.72% | 333,299 | 32.08M |
| 111 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 1.91% | 408,590 | 70.92M |
| 112 | LKFT | Lakefront Biotherapeutics NV | 1.90B | - | 42,602 | 1.20B |
| 113 | IOVA | Iovance Biotherapeutics, Inc. | 1.88B | -0.71% | 2,618,410 | 285.61M |
| 114 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | 5.76% | 346,934 | 42.95M |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.86B | 3.10% | 146,044 | - |
| 116 | MESO | Mesoblast Limited | 1.86B | -6.01% | 130,806 | 65.38M |
| 117 | SLS | SELLAS Life Sciences Group, Inc. | 1.84B | 8.12% | 4,023,779 | - |
| 118 | ZYME | Zymeworks Inc. | 1.83B | 2.88% | 113,279 | 81.26M |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 2.45% | 203,904 | 217.17M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -9.22% | 5,285,940 | 7.47M |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.80B | 6.65% | 256,359 | - |
| 122 | ANAB | AnaptysBio, Inc. | 1.79B | 5.37% | 81,590 | 232.39M |
| 123 | AKTS | Aktis Oncology, Inc. | 1.77B | 11.46% | 300,923 | 8.28M |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.75B | 2.61% | 237,835 | 11.13M |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | -0.93% | 646,995 | 2.18B |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | 1.86% | 5,128,167 | 66.41M |
| 127 | NBTX | Nanobiotix S.A. | 1.74B | -1.02% | 12,113 | 38.27M |
| 128 | INVA | Innoviva, Inc. | 1.74B | -0.47% | 82,828 | 420.69M |
| 129 | GHRS | GH Research PLC | 1.73B | 2.58% | 49,415 | - |
| 130 | URGN | UroGen Pharma Ltd. | 1.72B | -0.23% | 103,695 | 140.49M |
| 131 | ATAI | AtaiBeckley Inc. | 1.72B | 12.11% | 4,606,341 | 3.49M |
| 132 | VIR | Vir Biotechnology, Inc. | 1.72B | 2.31% | 261,129 | 65.50M |
| 133 | FTRE | Fortrea Holdings Inc. | 1.69B | 5.23% | 507,186 | 2.71B |
| 134 | SEPN | Septerna, Inc. | 1.60B | -1.30% | 69,468 | 72.26M |
| 135 | IMCR | Immunocore Holdings plc | 1.60B | 4.60% | 340,869 | 412.81M |
| 136 | AVBP | ArriVent BioPharma, Inc. | 1.58B | 6.18% | 412,012 | - |
| 137 | ABSI | Absci Corporation | 1.58B | 0.35% | 5,610,478 | 1.84M |
| 138 | ARDX | Ardelyx, Inc. | 1.56B | 2.26% | 597,724 | 427.68M |
| 139 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.55B | 4.17% | 1,855,681 | 204.73M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.54B | 4.52% | 250,496 | 20.00M |
| 141 | SVRA | Savara Inc. | 1.50B | 1.29% | 327,498 | - |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.48B | 0.60% | 569,476 | - |
| 143 | ZBIO | Zenas BioPharma, Inc. | 1.48B | 7.25% | 241,624 | 10.00M |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.47B | 8.36% | 62,094 | - |
| 145 | AAPG | Ascentage Pharma Group International | 1.46B | -0.15% | 3,267 | 82.08M |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.43B | 2.58% | 78,802 | - |
| 147 | NVAX | Novavax, Inc. | 1.41B | -3.71% | 1,038,864 | 596.34M |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 0.74% | 39,945 | 1.30M |
| 149 | IMTX | Immatics N.V. | 1.39B | 1.80% | 105,785 | 43.00M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.35B | 3.84% | 223,056 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | -0.89% | 15,850 | - |
| 152 | AVLN | Avalyn Pharma Inc. | 1.27B | 0.96% | 14,539 | - |
| 153 | EYPT | EyePoint, Inc. | 1.23B | 2.22% | 262,439 | 7.61M |
| 154 | MNKD | MannKind Corporation | 1.20B | 1.04% | 573,574 | 360.78M |
| 155 | WVE | Wave Life Sciences Ltd. | 1.17B | 2.18% | 774,479 | 71.80M |
| 156 | CGEM | Cullinan Therapeutics, Inc. | 1.14B | 4.82% | 196,439 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.13B | 4.74% | 239,926 | 79.76M |
| 158 | XNCR | Xencor, Inc. | 1.12B | 4.84% | 270,100 | 97.36M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 1.70% | 411,493 | - |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | 6.08% | 1,325,508 | 69.64M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.04B | 0.28% | 22,147 | - |
| 162 | SANA | Sana Biotechnology, Inc. | 1.02B | 3.96% | 746,459 | - |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | 4.76% | 582,414 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | 4.14% | 414,069 | - |
| 165 | DRTS | Alpha Tau Medical Ltd. | 985.62M | 8.76% | 306,944 | - |
| 166 | AVTX | Avalo Therapeutics, Inc. | 977.19M | 2.37% | 350,920 | 59.00K |
| 167 | REPL | Replimune Group, Inc. | 960.32M | 3.19% | 518,557 | - |
| 168 | KURA | Kura Oncology, Inc. | 956.99M | 1.51% | 493,886 | 71.64M |
| 169 | DBVT | DBV Technologies S.A. | 955.23M | 2.82% | 423,910 | 5.74M |
| 170 | SLDB | Solid Biosciences Inc. | 936.75M | 2.86% | 412,333 | - |
| 171 | GERN | Geron Corporation | 930.21M | 4.69% | 3,793,058 | 196.12M |
| 172 | PHAR | Pharming Group N.V. | 922.12M | 3.70% | 6,700 | 369.49M |
| 173 | ANRO | Alto Neuroscience, Inc. | 915.95M | 4.78% | 99,341 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 909.28M | 1.84% | 702,199 | 13.73M |
| 175 | ODTX | Odyssey Therapeutics, Inc. | 906.57M | 2.52% | 36,201 | 1.06M |
| 176 | TBPH | Theravance Biopharma, Inc. | 903.21M | 1.45% | 66,222 | 109.78M |
| 177 | ANNX | Annexon, Inc. | 902.77M | 3.96% | 697,334 | - |
| 178 | LBRX | LB Pharmaceuticals Inc | 896.72M | 2.59% | 69,613 | - |
| 179 | DSGN | Design Therapeutics, Inc. | 883.77M | 2.69% | 135,390 | - |
| 180 | EVMN | Evommune, Inc. | 881.01M | 3.82% | 86,922 | 10.00M |
| 181 | ABUS | Arbutus Biopharma Corporation | 875.09M | -0.67% | 599,748 | 191.45M |
| 182 | VOR | Vor Biopharma Inc. | 820.92M | 4.63% | 268,871 | - |
| 183 | PHAT | Phathom Pharmaceuticals, Inc. | 815.75M | -3.20% | 320,943 | 204.89M |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 783.50M | -25.14% | 2,891,032 | 98.99M |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 783.27M | 1.30% | 393,831 | 122.29M |
| 186 | AURA | Aura Biosciences, Inc. | 782.02M | 0.71% | 42,675 | - |
| 187 | OMER | Omeros Corporation | 768.63M | 0.38% | 200,322 | 9.89M |
| 188 | CLYM | Climb Bio, Inc. | 751.26M | 2.90% | 262,444 | - |
| 189 | IVA | Inventiva S.A. | 733.72M | 0.87% | 159,582 | 7.94M |
| 190 | ALLO | Allogene Therapeutics, Inc. | 731.73M | 3.41% | 2,158,433 | 22.00K |
| 191 | CTMX | CytomX Therapeutics, Inc. | 718.42M | -0.60% | 618,460 | 35.54M |
| 192 | OCS | Oculis Holding AG | 716.81M | 2.68% | 171,674 | 1.40M |
| 193 | IMMX | Immix Biopharma, Inc. | 711.90M | -0.40% | 381,059 | - |
| 194 | CADL | Candel Therapeutics, Inc. | 699.73M | 3.02% | 566,418 | - |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 684.58M | 1.23% | 63,280 | 299.77M |
| 196 | RLMD | Relmada Therapeutics, Inc. | 681.79M | -0.15% | 671,672 | - |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 681.56M | 1.88% | 366,766 | 8.37M |
| 198 | NVCT | Nuvectis Pharma, Inc. | 679.58M | 4.66% | 230,933 | - |
| 199 | SGP | SpyGlass Pharma, Inc. | 671.34M | 2.71% | 16,926 | - |
| 200 | AGMB | AgomAb Therapeutics NV | 661.89M | 5.99% | 34,832 | - |
| 201 | TENX | Tenax Therapeutics, Inc. | 661.64M | 0.15% | 195,932 | - |
| 202 | DRUG | Bright Minds Biosciences Inc. | 660.55M | 0.24% | 15,874 | - |
| 203 | DNA | Ginkgo Bioworks Holdings, Inc. | 653.24M | 2.77% | 588,490 | 151.40M |
| 204 | SLBT | SL Science Holding Limited | 646.50M | 6.67% | 68,533 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 626.44M | 5.11% | 96,285 | - |
| 206 | CRMD | CorMedix Inc. | 623.69M | -5.24% | 880,106 | 400.05M |
| 207 | MNPR | Monopar Therapeutics Inc. | 618.97M | 3.83% | 94,111 | - |
| 208 | FDMT | 4D Molecular Therapeutics, Inc. | 618.17M | 1.76% | 333,218 | 88.24M |
| 209 | TRAX | First Tracks Biotherapeutics, Inc. | 617.25M | 5.99% | 128,145 | - |
| 210 | FTH | Faeth Therapeutics, Inc. | 605.54M | -4.28% | 22,124 | - |
| 211 | CBIO | Crescent Biopharma, Inc. | 595.30M | 3.20% | 25,690 | 11.88M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 593.00M | 0.15% | 20,747 | 117.05M |
| 213 | TECX | Tectonic Therapeutic, Inc. | 587.02M | 1.27% | 22,068 | - |
| 214 | ALT | Altimmune, Inc. | 567.86M | -1.02% | 760,801 | 36.00K |
| 215 | MDXG | MiMedx Group, Inc. | 566.74M | -0.65% | 188,077 | 389.42M |
| 216 | PRME | Prime Medicine, Inc. | 565.33M | 0.32% | 1,028,573 | 4.03M |
| 217 | EIKN | Eikon Therapeutics, Inc. | 560.33M | 7.48% | 102,921 | - |
| 218 | ACHV | Achieve Life Sciences, Inc. | 551.28M | 1.32% | 752,962 | - |
| 219 | RGNX | REGENXBIO Inc. | 551.10M | 6.92% | 490,025 | 87.82M |
| 220 | PROK | ProKidney Corp. | 530.11M | -0.85% | 276,729 | 889.00K |
| 221 | XOMA | XOMA Royalty Corporation | 527.98M | -0.12% | 18,156 | 48.56M |
| 222 | STRO | Sutro Biopharma, Inc. | 526.36M | 5.78% | 77,736 | 99.61M |
| 223 | ARVN | Arvinas, Inc. | 524.23M | 0.93% | 130,616 | 89.40M |
| 224 | RZLT | Rezolute, Inc. | 523.38M | -0.40% | 185,402 | - |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 516.76M | -1.39% | 589,341 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 506.93M | -0.16% | 60,509 | 71.10M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 502.47M | 4.84% | 29,942 | - |
| 228 | CABA | Cabaletta Bio, Inc. | 498.13M | 0.83% | 1,337,256 | - |
| 229 | PRTA | Prothena Corporation plc | 491.34M | -0.16% | 107,748 | 57.94M |
| 230 | NGNE | Neurogene Inc. | 489.86M | 3.09% | 36,849 | 925.00K |
| 231 | STTK | Shattuck Labs, Inc. | 489.22M | 6.16% | 398,289 | 1.00M |
| 232 | VALN | Valneva SE | 489.20M | -2.29% | 14,803 | 180.25M |
| 233 | BNTC | Benitec Biopharma Inc. | 486.63M | 3.93% | 73,417 | - |
| 234 | OCGN | Ocugen, Inc. | 477.32M | 1.44% | 1,905,948 | 4.47M |
| 235 | CCCC | C4 Therapeutics, Inc. | 476.54M | 1.41% | 631,472 | 34.86M |
| 236 | FBRX | Forte Biosciences, Inc. | 466.97M | 3.07% | 34,123 | - |
| 237 | ARTV | Artiva Biotherapeutics, Inc. | 464.75M | 2.63% | 73,407 | 251.00K |
| 238 | SLN | Silence Therapeutics plc | 463.84M | 7.21% | 456,600 | 839.00K |
| 239 | OVID | Ovid Therapeutics Inc. | 462.87M | -0.80% | 422,684 | 7.12M |
| 240 | EDIT | Editas Medicine, Inc. | 451.95M | 5.18% | 1,363,241 | 38.69M |
| 241 | AUTL | Autolus Therapeutics plc | 444.46M | 5.03% | 277,633 | 92.62M |
| 242 | VTVT | vTv Therapeutics Inc. | 438.18M | -1.20% | 29,606 | 36.84M |
| 243 | ZURA | Zura Bio Limited | 436.99M | 7.98% | 324,848 | - |
| 244 | IPSC | Century Therapeutics, Inc. | 436.46M | 5.68% | 406,009 | 109.16M |
| 245 | SGMT | Sagimet Biosciences Inc. | 433.19M | 1.23% | 132,415 | - |
| 246 | PRLD | Prelude Therapeutics Incorporated | 431.42M | 1.87% | 81,068 | 16.72M |
| 247 | ANL | Adlai Nortye Ltd. | 422.80M | -3.82% | 24,825 | 5.00M |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 408.11M | 1.04% | 37,063 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 406.81M | 1.97% | 38,737 | 69.21M |
| 250 | PBYI | Puma Biotechnology, Inc. | 403.12M | -0.38% | 57,183 | 227.18M |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 394.26M | 2.20% | 138,994 | 9.01M |
| 252 | LRMR | Larimar Therapeutics, Inc. | 393.52M | 3.86% | 477,201 | - |
| 253 | LXEO | Lexeo Therapeutics, Inc. | 382.40M | -0.41% | 195,986 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 374.58M | 2.97% | 720,768 | 850.00K |
| 255 | INDP | Indaptus Therapeutics, Inc. | 373.70M | -7.04% | 44,488 | - |
| 256 | OABI | OmniAb, Inc. | 371.13M | 12.28% | 213,591 | 28.94M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 369.07M | 2.42% | 453,617 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 363.35M | 0.58% | 29,026 | 51.00M |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 358.11M | 0.93% | 128,857 | 217.78M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 352.92M | -1.56% | 90,475 | - |
| 261 | UPB | Upstream Bio, Inc. | 352.64M | 2.05% | 104,278 | 3.32M |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 341.08M | -0.47% | 24,622 | - |
| 263 | PALI | Palisade Bio, Inc. | 331.54M | -0.52% | 402,405 | - |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 326.36M | 2.41% | 98,670 | 1.00 |
| 265 | VSTM | Verastem, Inc. | 322.06M | -4.81% | 1,230,533 | 49.59M |
| 266 | ABEO | Abeona Therapeutics Inc. | 320.31M | - | 464,109 | 14.54M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 317.81M | 4.77% | 32,559 | 31.00K |
| 268 | GLSI | Greenwich LifeSciences, Inc. | 317.56M | 0.51% | 63,048 | - |
| 269 | LCTX | Lineage Cell Therapeutics, Inc. | 312.87M | -0.40% | 226,697 | 14.78M |
| 270 | IMRX | Immuneering Corporation | 306.67M | 3.04% | 431,051 | - |
| 271 | IRD | Opus Genetics, Inc. | 303.61M | 0.54% | 297,162 | 11.98M |
| 272 | HELP | Cybin Inc. | 302.22M | 18.66% | 4,202,728 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 302.03M | 2.86% | 127,728 | 114.70K |
| 274 | MGNX | MacroGenics, Inc. | 300.02M | -1.26% | 342,324 | 157.08M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 298.39M | -2.53% | 331,334 | - |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 293.55M | -2.12% | 156,469 | - |
| 277 | SRZN | Surrozen, Inc. | 293.05M | 1.98% | 12,440 | 7.49M |
| 278 | IFRX | InflaRx N.V. | 286.48M | 0.78% | 143,781 | 33.82K |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 281.90M | -0.25% | 415,362 | 26.87M |
| 280 | IVVD | Invivyd, Inc. | 281.11M | 2.18% | 592,164 | 55.87M |
| 281 | ADAG | Adagene Inc. | 280.81M | - | 156,130 | 7.67M |
| 282 | BCYC | Bicycle Therapeutics plc | 279.24M | 1.01% | 158,129 | 63.50M |
| 283 | NMRA | Neumora Therapeutics, Inc. | 276.07M | 2.05% | 294,489 | - |
| 284 | GALT | Galectin Therapeutics Inc. | 273.96M | 6.12% | 905,892 | - |
| 285 | RNAC | Cartesian Therapeutics, Inc. | 273.39M | -3.48% | 91,918 | 1.78M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 272.03M | 0.82% | 349,464 | 5.20M |
| 287 | NAGE | Niagen Bioscience, Inc. | 271.36M | -1.45% | 89,452 | 130.42M |
| 288 | CNXU | Conexeu Sciences Inc. | 267.58M | -6.45% | 31,515 | - |
| 289 | TRDA | Entrada Therapeutics, Inc. | 267.37M | -1.59% | 55,034 | 5.74M |
| 290 | FATE | Fate Therapeutics, Inc. | 250.02M | 4.13% | 905,448 | 6.32M |
| 291 | ACIU | AC Immune SA | 249.49M | -0.98% | 24,261 | 4.62M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 248.54M | -0.80% | 342,453 | 80.00M |
| 293 | ALXO | ALX Oncology Holdings Inc. | 247.60M | 2.79% | 213,183 | - |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 246.78M | 2.85% | 7,606 | 18.47M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 241.90M | 0.98% | 17,167 | 28.22M |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 241.32M | 1.26% | 44,644 | 32.72M |
| 297 | CHRS | Coherus Oncology, Inc. | 236.00M | 0.66% | 202,332 | 46.88M |
| 298 | AVXL | Anavex Life Sciences Corp. | 233.07M | -1.76% | 231,014 | - |
| 299 | TARA | Protara Therapeutics, Inc. | 229.31M | 1.24% | 94,975 | - |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 228.85M | -3.08% | 234,162 | 7.15M |
| 301 | UNCY | Unicycive Therapeutics, Inc. | 223.75M | 6.21% | 444,825 | - |
| 302 | VYGR | Voyager Therapeutics, Inc. | 222.95M | 0.27% | 113,144 | 36.49M |
| 303 | RNA | Atrium Therapeutics, Inc. | 222.80M | 1.52% | 22,829 | 36.68M |
| 304 | KPTI | Karyopharm Therapeutics Inc. | 216.66M | 4.82% | 83,501 | 151.12M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 214.97M | 2.73% | 28,670 | 3.93M |
| 306 | ALEC | Alector, Inc. | 214.28M | 7.82% | 2,255,973 | 18.42M |
| 307 | NERV | Minerva Neurosciences, Inc. | 213.14M | 5.66% | 47,749 | - |
| 308 | NGEN | NervGen Pharma Corp. | 212.94M | 0.75% | 161,156 | - |
| 309 | KROS | Keros Therapeutics, Inc. | 211.97M | -1.92% | 43,403 | 33.18M |
| 310 | NKTX | Nkarta, Inc. | 211.77M | 2.42% | 120,362 | - |
| 311 | IMUX | Immunic, Inc. | 209.50M | 4.55% | 45,682 | - |
| 312 | CDXS | Codexis, Inc. | 208.15M | 0.88% | 347,845 | 78.09M |
| 313 | CLLS | Cellectis S.A. | 203.52M | 0.49% | 2,768 | 75.11M |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 201.80M | 1.28% | 83,003 | 54.71M |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 200.34M | 7.69% | 345,121 | - |
| 316 | OTLK | Outlook Therapeutics, Inc. | 198.22M | -2.38% | 4,063,743 | 333.14K |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.67M | 2.48% | 375,947 | 17.56M |
| 318 | ORMP | Oramed Pharmaceuticals Inc. | 195.63M | 11.16% | 242,279 | 2.00M |
| 319 | CGEN | Compugen Ltd. | 194.84M | 2.49% | 50,762 | 72.66M |
| 320 | MDWD | MediWound Ltd. | 191.50M | 0.34% | 5,748 | 14.48M |
| 321 | NBP | NovaBridge Biosciences | 190.82M | 3.12% | 99,593 | - |
| 322 | EQ | Equillium, Inc. | 190.63M | 5.79% | 115,477 | 4.39M |
| 323 | ANTX | AN2 Therapeutics, Inc. | 190.17M | 1.54% | 52,389 | - |
| 324 | KRRO | Korro Bio, Inc. | 189.73M | -4.47% | 44,662 | 3.84M |
| 325 | QTTB | Q32 Bio Inc. | 187.03M | -1.16% | 75,452 | 53.74M |
| 326 | TTRX | Turn Therapeutics Inc. | 183.20M | 0.99% | 1,929 | - |
| 327 | DTIL | Precision BioSciences, Inc. | 179.33M | 3.12% | 77,161 | 45.07M |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | -0.89% | 94,533 | 76.38M |
| 329 | IPHA | Innate Pharma S.A. | 176.92M | -4.21% | 1,160 | 10.57M |
| 330 | OKUR | OnKure Therapeutics, Inc. | 176.53M | 0.69% | 52,096 | - |
| 331 | YDES | YD Bio Limited | 175.80M | -4.94% | 15,676 | 510.36K |
| 332 | KZIA | Kazia Therapeutics Limited | 171.86M | 2.80% | 66,108 | 1.27M |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 170.74M | -1.18% | 1,110,799 | 1.78M |
| 334 | LENZ | LENZ Therapeutics, Inc. | 170.25M | -2.69% | 152,296 | 20.99M |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 168.29M | 0.87% | 110,358 | - |
| 336 | CRBU | Caribou Biosciences, Inc. | 164.64M | - | 473,322 | 11.20M |
| 337 | PRQR | ProQR Therapeutics N.V. | 158.57M | -16.85% | 6,236,520 | 15.73M |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 158.43M | -0.11% | 486,795 | 225.00K |
| 339 | HURA | TuHURA Biosciences, Inc. | 157.93M | -1.59% | 83,479 | - |
| 340 | HUMA | Humacyte, Inc. | 157.81M | 1.88% | 4,870,713 | 2.02M |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 155.82M | 2.87% | 78,363 | - |
| 342 | TLSA | Tiziana Life Sciences Ltd | 147.41M | 1.79% | 47,834 | - |
| 343 | SPRB | Spruce Biosciences, Inc. | 144.74M | 1.39% | 9,379 | 697.00K |
| 344 | MOLN | Molecular Partners AG | 144.12M | -1.05% | 117 | 856.30K |
| 345 | ACOG | Alpha Cognition Inc. | 142.62M | -0.46% | 17,640 | 10.83M |
| 346 | PYXS | Pyxis Oncology, Inc. | 142.55M | 3.69% | 225,597 | 13.86M |
| 347 | ENLV | Enlivex Ltd. | 142.22M | -2.50% | 178,557 | - |
| 348 | CNTB | Connect Biopharma Holdings Limited | 134.74M | 0.94% | 37,765 | 233.00K |
| 349 | ADCT | ADC Therapeutics SA | 132.28M | -2.80% | 241,456 | 79.18M |
| 350 | MENS | Jyong Biotech Ltd. | 130.65M | 1.15% | 72,911 | - |
| 351 | GNLX | Genelux Corporation | 128.34M | 1.40% | 49,952 | 8.00K |
| 352 | NRXP | NRx Pharmaceuticals, Inc. | 127.41M | -1.12% | 302,431 | 2.29M |
| 353 | COYA | Coya Therapeutics, Inc. | 125.97M | 0.94% | 49,854 | 7.94M |
| 354 | GUTS | Fractyl Health, Inc. | 125.55M | 2.12% | 320,686 | 3.00K |
| 355 | AGEN | Agenus Inc. | 124.09M | 2.05% | 141,815 | 123.87M |
| 356 | PEPG | PepGen Inc. | 123.81M | 1.13% | 88,392 | - |
| 357 | SPRO | Spero Therapeutics, Inc. | 120.44M | -0.95% | 437,825 | 61.19M |
| 358 | ENGN | enGene Therapeutics Inc. | 120.25M | 2.57% | 968,303 | - |
| 359 | NTHI | NeOnc Technologies Holdings, Inc. | 118.10M | -0.96% | 13,812 | 39.99K |
| 360 | ALDX | Aldeyra Therapeutics, Inc. | 114.91M | 0.26% | 397,382 | - |
| 361 | ONCY | Oncolytics Biotech Inc. | 114.50M | 4.10% | 350,659 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 114.10M | 0.42% | 10,395 | - |
| 363 | AARD | Aardvark Therapeutics, Inc. | 112.79M | 4.23% | 101,982 | - |
| 364 | ALPS | Alps Group Inc | 109.16M | 0.92% | 63,505 | 3.74M |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 107.88M | 7.35% | 33,190 | 37.16M |
| 366 | CUE | Cue Biopharma, Inc. | 107.49M | 2.15% | 10,256 | 32.73M |
| 367 | FBIO | Fortress Biotech, Inc. | 105.97M | 1.59% | 269,584 | 66.16M |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 105.44M | -1.08% | 623,083 | 70.00M |
| 369 | CBUS | Cibus, Inc. | 105.34M | 0.73% | 45,654 | 4.29M |
| 370 | VANI | Vivani Medical, Inc. | 104.34M | -0.82% | 183,908 | - |
| 371 | KLRS | Kalaris Therapeutics, Inc. | 103.14M | -1.48% | 13,800 | - |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 100.37M | 5.59% | 17,372 | 23.14M |
| 373 | CGTX | Cognition Therapeutics, Inc. | 99.79M | 9.31% | 2,393,824 | - |
| 374 | PTHS | Pelthos Therapeutics Inc. | 97.32M | -2.47% | 23,224 | 27.70M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 95.69M | 4.20% | 8,389 | - |
| 376 | SEER | Seer, Inc. | 94.51M | 1.71% | 37,138 | 15.17M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 94.30M | -0.76% | 269,417 | 3.17M |
| 378 | ANIX | Anixa Biosciences, Inc. | 91.86M | -1.46% | 146,257 | - |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 91.73M | 1.36% | 390,564 | 65.34K |
| 380 | PYPD | PolyPid Ltd. | 91.08M | -0.21% | 23,351 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 90.74M | 0.40% | 231,135 | - |
| 382 | RNTX | Rein Therapeutics Inc. | 90.51M | -3.68% | 93,869 | - |
| 383 | ICCC | ImmuCell Corporation | 89.11M | 0.61% | 1,104 | 29.93M |
| 384 | CRDF | Cardiff Oncology, Inc. | 88.20M | 2.38% | 270,745 | 525.00K |
| 385 | NRXS | NeurAxis, Inc. | 86.81M | 3.09% | 29,299 | 4.28M |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 86.31M | 2.03% | 14,433 | - |
| 387 | ACET | Adicet Bio, Inc. | 86.11M | -0.61% | 15,908 | - |
| 388 | ATHE | Alterity Therapeutics Limited | 85.53M | -2.67% | 32,018 | 4.43M |
| 389 | LIXT | Lixte Biotechnology Holdings, Inc. | 85.32M | 0.29% | 51,129 | - |
| 390 | CSBR | Champions Oncology, Inc. | 85.27M | - | 5,161 | 57.95M |
| 391 | GOSS | Gossamer Bio, Inc. | 85.21M | 3.14% | 2,968,147 | 55.54M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 84.51M | - | 129,356 | - |
| 393 | RLYB | Rallybio Corporation | 84.37M | 0.03% | 25,104 | 858.00K |
| 394 | OKYO | OKYO Pharma Limited | 83.97M | 3.23% | 31,204 | - |
| 395 | IBIO | iBio, Inc. | 80.98M | 0.62% | 116,274 | 300.00K |
| 396 | LONA | LeonaBio, Inc. | 80.88M | 0.23% | 428 | - |
| 397 | HRTX | Heron Therapeutics, Inc. | 79.99M | -2.47% | 393,772 | 150.71M |
| 398 | OSTX | OS Therapies Incorporated | 79.72M | -0.56% | 241,961 | - |
| 399 | HYFT | MindWalk Holdings Corp. | 76.73M | -0.32% | 105,238 | 20.70M |
| 400 | ENTX | Entera Bio Ltd. | 75.81M | - | 153,210 | 42.00K |
| 401 | GANX | Gain Therapeutics, Inc. | 74.22M | - | 117,043 | - |
| 402 | XBIT | XBiotech Inc. | 71.64M | 0.42% | 790 | - |
| 403 | ANVS | Annovis Bio, Inc. | 71.47M | -1.18% | 521,722 | - |
| 404 | ELTX | Elicio Therapeutics, Inc. | 70.57M | -7.04% | 450,570 | - |
| 405 | EDSA | Edesa Biotech, Inc. | 70.07M | -0.88% | 51,380 | - |
| 406 | PLRX | Pliant Therapeutics, Inc. | 70.05M | 0.88% | 84,190 | - |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 69.34M | - | 144,095 | - |
| 408 | IMA | ImageneBio, Inc. | 67.67M | - | 268 | 800.00K |
| 409 | BYSI | BeyondSpring Inc. | 66.61M | -1.52% | 3,035 | 1.88M |
| 410 | MNOV | MediciNova, Inc. | 65.96M | 0.75% | 3,932 | 596.64K |
| 411 | CING | Cingulate Inc. | 64.65M | 1.25% | 41,457 | - |
| 412 | MCRB | Seres Therapeutics, Inc. | 64.20M | -2.64% | 33,304 | 1.15M |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 64.00M | 1.69% | 91,170 | - |
| 414 | VRXA | Veraxa Biotech AG | 61.03M | 5.22% | 354,660 | - |
| 415 | EXOZ | eXoZymes, Inc. | 60.88M | 0.56% | 861 | -700.00 |
| 416 | INKT | MiNK Therapeutics, Inc. | 59.78M | -0.91% | 2,308 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 58.14M | 1.00% | 131,994 | 9.14M |
| 418 | FLNA | Filana Therapeutics, Inc. | 57.49M | 0.85% | 154,295 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 56.37M | 2.39% | 562,371 | 190.00K |
| 420 | BOLD | Boundless Bio, Inc. | 56.16M | -3.85% | 377,601 | - |
| 421 | XLO | Xilio Therapeutics, Inc. | 53.43M | -0.89% | 2,808 | 53.48M |
| 422 | CNTX | Context Therapeutics Inc. | 53.29M | 0.69% | 820,026 | - |
| 423 | PDSB | PDS Biotechnology Corporation | 51.96M | 6.55% | 345,745 | - |
| 424 | IMMP | Immutep Limited | 51.85M | -0.88% | 370,125 | 5.28M |
| 425 | TIL | Instil Bio, Inc. | 51.54M | -0.52% | 4,953 | - |
| 426 | KALA | KALA BIO, Inc. | 51.31M | -8.00% | 20,349 | - |
| 427 | IBO | Impact BioMedical Inc. | 51.12M | -4.74% | 58,778 | 39.00K |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 51.12M | 0.66% | 3,362 | - |
| 429 | MREO | Mereo BioPharma Group plc | 49.67M | 2.30% | 353,415 | 500.00K |
| 430 | APLM | Apollomics, Inc. | 49.41M | 9.76% | 15,779 | 8.84M |
| 431 | LTRN | Lantern Pharma Inc. | 48.16M | -4.43% | 95,102 | - |
| 432 | VERU | Veru Inc. | 47.19M | -1.01% | 83,345 | 16.89M |
| 433 | HYPD | Hyperion DeFi, Inc. | 46.99M | -8.82% | 1,145,251 | 1.04M |
| 434 | ELOX | Eloxx Pharmaceuticals, Inc. | 46.46M | -4.08% | 4,847 | - |
| 435 | RADX | Radiopharm Theranostics Limited | 46.45M | 2.44% | 15,484 | 10.86M |
| 436 | ACTU | Actuate Therapeutics, Inc. | 45.94M | -1.54% | 20,879 | - |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | 0.83% | 30,747 | 22.33M |
| 438 | CRVO | CervoMed Inc. | 43.69M | -0.92% | 348,852 | 2.09M |
| 439 | RNXT | RenovoRx, Inc. | 42.85M | -0.30% | 173,737 | 1.49M |
| 440 | GNTA | Genenta Science S.p.A. | 41.76M | -4.32% | 182,688 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 41.74M | -1.02% | 23,475 | - |
| 442 | TVGN | Tevogen Bio Holdings Inc. | 40.16M | -2.34% | 4,807 | - |
| 443 | NTRB | Nutriband Inc. | 39.99M | 4.78% | 2,583 | 1.80M |
| 444 | INMB | INmune Bio Inc. | 38.28M | 6.67% | 8,701,189 | 50.00K |
| 445 | GRCE | Grace Therapeutics, Inc. | 38.24M | 0.86% | 68,371 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 36.14M | 7.52% | 88,615 | 797.92K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.65M | 0.45% | 8,763 | 4.71M |
| 448 | SNTI | Senti Biosciences Holdings, Inc. | 33.64M | - | 143,165 | 38.00K |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 31.69M | - | 38,759 | 90.00K |
| 450 | DARE | Daré Bioscience, Inc. | 31.61M | 1.44% | 109,626 | 1.16M |
| 451 | LSTA | Lisata Therapeutics, Inc. | 30.92M | -1.31% | 10,551 | 170.00K |
| 452 | GRDX | GridAI Technologies Corp. | 30.60M | 4.07% | 7,707 | - |
| 453 | NNVC | NanoViricides, Inc. | 29.61M | -4.41% | 98,698 | - |
| 454 | DYAI | Dyadic International, Inc. | 28.97M | 8.76% | 437,227 | 3.81M |
| 455 | LITS | Lite Strategy, Inc. | 28.86M | -2.85% | 105,985 | - |
| 456 | PSTV | Plus Therapeutics, Inc. | 28.29M | 3.79% | 833,664 | 5.18M |
| 457 | KYNB | Kyntra Bio, Inc. | 28.09M | - | 203 | 7.44M |
| 458 | SER | Serina Therapeutics, Inc. | 27.75M | 0.54% | 6,901 | 130.00K |
| 459 | EVAX | Evaxion A/S | 27.52M | -2.37% | 14,866 | 7.53M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 27.23M | 1.00% | 2,456 | 14.97M |
| 461 | IGC | IGC Pharma, Inc. | 26.82M | -0.15% | 201,385 | 1.11M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 26.51M | -1.32% | 129,039 | - |
| 463 | BCTX | BriaCell Therapeutics Corp. | 26.29M | -0.50% | 46,956 | - |
| 464 | VTGN | Vistagen Therapeutics, Inc. | 25.77M | -5.54% | 265,032 | 1.27M |
| 465 | QNTM | Quantum BioPharma Ltd. | 25.18M | 5.37% | 53,703 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 24.89M | 4.32% | 13,555 | - |
| 467 | LGVN | Longeveron Inc. | 24.61M | 6.76% | 23,972 | 1.22M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 23.73M | -2.23% | 4,117 | -13.27K |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 23.55M | 6.81% | 13,067 | - |
| 470 | PLUR | Pluri Inc. | 22.58M | -1.26% | 3,766 | 1.08M |
| 471 | MRKR | Marker Therapeutics, Inc. | 22.34M | 2.29% | 29,631 | 3.55M |
| 472 | PLRZ | Polyrizon Ltd. | 21.57M | -3.50% | 9,592 | - |
| 473 | VYNE | VYNE Therapeutics Inc. | 21.55M | -0.68% | 7,057 | 454.00K |
| 474 | PTN | Palatin Technologies, Inc. | 21.33M | 2.88% | 3,352 | 12.88M |
| 475 | ALLR | Allarity Therapeutics, Inc. | 20.76M | 0.38% | 59,953 | 345.00K |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.06M | 0.81% | 33,520 | - |
| 477 | LPCN | Lipocine Inc. | 19.99M | -1.82% | 9,086 | 2.00M |
| 478 | CELU | Celularity Inc. | 19.44M | -0.70% | 10,672 | 26.55M |
| 479 | AEON | AEON Biopharma, Inc. | 18.94M | -0.69% | 3,495 | - |
| 480 | NCEL | NewcelX Ltd. | 18.68M | -3.34% | 1,911 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 18.01M | -3.04% | 38,569 | - |
| 482 | CVM | CEL-SCI Corporation | 17.30M | -0.50% | 184,914 | - |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 17.08M | -6.18% | 104,854 | 1.14M |
| 484 | TPST | Tempest Therapeutics, Inc. | 16.51M | -3.88% | 80,108 | - |
| 485 | LNAI | Lunai Bioworks Inc. | 16.50M | 6.12% | 49,032 | 20.94K |
| 486 | MLEC | Moolec Science SA | 16.38M | 3.36% | 5,507 | 7.83M |
| 487 | XCUR | Exicure, Inc. | 16.22M | -5.39% | 22,647 | 500.00K |
| 488 | MBRX | Moleculin Biotech, Inc. | 15.90M | 1.71% | 322,721 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 15.79M | 0.91% | 41,231 | 5.61M |
| 490 | QNCX | Quince Therapeutics, Inc. | 15.68M | 1.05% | 53,973 | - |
| 491 | ATOS | Atossa Therapeutics, Inc. | 15.24M | 1.14% | 65,431 | - |
| 492 | GTBP | GT Biopharma, Inc. | 15.22M | -7.48% | 659,698 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.16M | 2.86% | 7,923 | 152.72K |
| 494 | BIVI | BioVie Inc. | 14.86M | 2.60% | 118,393 | - |
| 495 | INAB | IN8bio, Inc. | 14.57M | 0.01% | 1,891 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 14.55M | 0.48% | 12,457 | 225.00K |
| 497 | BLRX | BioLineRx Ltd. | 14.03M | -6.82% | 1,613 | 1.40M |
| 498 | LEXX | Lexaria Bioscience Corp. | 13.63M | 0.55% | 20,953 | 368.00K |
| 499 | CYCN | Cyclerion Therapeutics, Inc. | 13.53M | 1.59% | 5,981 | 1.99M |
| 500 | JSPR | Jasper Therapeutics, Inc. | 13.44M | -2.16% | 61,849 | - |